AI-generated summary
The authors report a prospective cohort study of 17 patients with severe chronic ocular graft-versus-host disease treated with intense pulsed light alongside conventional care, with follow-up to 12 weeks. They describe no adverse reactions, improved symptoms and most signs, and increased conjunctival goblet cell density. The authors conclude that the treatment can effectively increase tear film stability without significant side effects.
- Participants
- 17
- Who or what was studied
- 17 patients with severe chronic ocular graft-versus-host disease
- Limits stated in the abstract
- The abstract describes an uncontrolled prospective cohort of 17 patients, a small sample without a comparison group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: GRADE, Dry eye. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.